RPT Realty (NYSE:RPT – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.83 and traded as high as $10.96. RPT Realty shares last traded at $10.76, with a volume of 421,332 shares traded. Analysts Set New Price Targets A […]
RPT Realty (NYSE:RPT – Get Rating)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $9.82 and traded as high as $9.85. RPT Realty shares last traded at $9.81, with a volume of 889,473 shares traded. Wall Street Analysts Forecast Growth Several analysts […]
Sarepta Therapeutics, Inc. announced Friday that the U.S. Food and Drug Administration or FDA has accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.